TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs8192583
log Bayes Factor = 58.0993
Chromosome 6   position 32,163,274  (GRCh37) Explore rs8192583 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
L40 Psoriasis
1.000 0.000 0.000
J40-J47 Chronic lower respiratory diseases
0.000 0.000 1.000
J47 Bronchiectasis
0.000 0.000 1.000
J45 Asthma
0.000 0.000 1.000
J45.9 Asthma, unspecified
0.000 0.000 1.000
Chapter V Mental and behavioural disorders
1.000 0.000 0.000
J33 Nasal polyp
0.000 0.000 1.000
Chapter X Diseases of the respiratory system
0.000 0.001 0.999
J30-J39 Other diseases of upper respiratory tract
0.000 0.001 0.999
F30-F39 Mood [affective] disorders
0.999 0.001 0.000
# Top node
0.997 0.003 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.997 0.003 0.000
J33.9 Nasal polyp, unspecified
0.000 0.003 0.997
L40-L45 Papulosquamous disorders
0.997 0.003 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.996 0.004 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.995 0.005 0.000
Chapter VI Diseases of the nervous system
0.993 0.007 0.000
J33.0 Polyp of nasal cavity
0.000 0.008 0.992
F40-F48 Neurotic, stress-related and somatoform disorders
0.990 0.010 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.986 0.014 0.000
F31 Bipolar affective disorder
0.985 0.015 0.000
G50-G59 Nerve, nerve root and plexus disorders
0.981 0.019 0.000
F60-F69 Disorders of adult personality and behaviour
0.976 0.024 0.000
G56 Mononeuropathies of upper limb
0.975 0.025 0.000
L40.0 Psoriasis vulgaris
0.973 0.027 0.000
T39.1 4-Aminophenol derivatives
0.970 0.030 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.034 0.966
F41 Other anxiety disorders
0.964 0.036 0.000
G56.0 Carpal tunnel syndrome
0.964 0.036 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.036 0.964
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.956 0.044 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.953 0.047 0.000
F60 Specific personality disorders
0.952 0.048 0.000
J44 Other chronic obstructive pulmonary disease
0.000 0.051 0.949
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.066 0.934
F30 Manic episode
0.930 0.070 0.000
F31.9 Bipolar affective disorder, unspecified
0.928 0.072 0.000
G51 Facial nerve disorders
0.912 0.088 0.000
F60.9 Personality disorder, unspecified
0.910 0.090 0.000
J32 Chronic sinusitis
0.000 0.094 0.906
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.898 0.102 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.894 0.106 0.000
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.106 0.894
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.108 0.892
J33.8 Other polyp of sinus
0.000 0.108 0.892
F33 Recurrent depressive disorder
0.889 0.111 0.000
G20-G26 Extrapyramidal and movement disorders
0.884 0.116 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.883 0.117 0.000
J00-J06 Acute upper respiratory infections
0.000 0.117 0.883
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.882 0.118 0.000
J80-J84 Other respiratory diseases principally affecting the interstitium
0.000 0.119 0.881
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.877 0.123 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.128 0.872
G56.2 Lesion of ulnar nerve
0.871 0.129 0.000
G70-G73 Diseases of myoneural junction and muscle
0.870 0.129 0.000
J45.0 Predominantly allergic asthma
0.000 0.134 0.866
F17 Mental and behavioural disorders due to use of tobacco
0.865 0.135 0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.135 0.865
F32 Depressive episode
0.864 0.136 0.000
G90-G99 Other disorders of the nervous system
0.863 0.137 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.859 0.141 0.000
J03 Acute tonsillitis
0.000 0.142 0.858
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.856 0.144 0.000
F41.1 Generalised anxiety disorder
0.855 0.145 0.000
F30.0 Hypomania
0.851 0.149 0.000
F60.3 Emotionally unstable personality disorder
0.843 0.157 0.000
J03.9 Acute tonsillitis, unspecified
0.000 0.159 0.841
F31.8 Other bipolar affective disorders
0.840 0.160 0.000
F41.2 Mixed anxiety and depressive disorder
0.839 0.161 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.838 0.162 0.000
J32.0 Chronic maxillary sinusitis
0.000 0.164 0.836
F44 Dissociative [conversion] disorders
0.834 0.166 0.000
T42.4 Benzodiazepines
0.831 0.169 0.000
Q80-Q89 Other congenital malformations
0.830 0.170 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.828 0.172 0.000
T51 Toxic effect of alcohol
0.828 0.172 0.000
F17.1 Harmful use
0.822 0.178 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.821 0.179 0.000
L50-L54 Urticaria and erythema
0.820 0.180 0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.818 0.182 0.000
G51.0 Bell's palsy
0.818 0.182 0.000
F45 Somatoform disorders
0.817 0.183 0.000
J60-J70 Lung diseases due to external agents
0.000 0.193 0.807
Chapter VIII Diseases of the ear and mastoid process
0.805 0.195 0.000
J84 Other interstitial pulmonary diseases
0.000 0.195 0.805
J42 Unspecified chronic bronchitis
0.000 0.196 0.804
L42 Pityriasis rosea
0.803 0.197 0.000
Q50-Q56 Congenital malformations of genital organs
0.800 0.200 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.799 0.201 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.799 0.201 0.000
L40.8 Other psoriasis
0.798 0.201 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.202 0.798
T43.2 Other and unspecified antidepressants
0.792 0.208 0.000
S10-S19 Injuries to the neck
0.791 0.209 0.000
G70 Myasthenia gravis and other myoneural disorders
0.790 0.210 0.000
G20 Parkinson's disease
0.787 0.213 0.000
J30 Vasomotor and allergic rhinitis
0.000 0.213 0.787
F31.0 Bipolar affective disorder, current episode hypomanic
0.782 0.218 0.000
F34 Persistent mood [affective] disorders
0.781 0.219 0.000
F42 Obsessive-compulsive disorder
0.781 0.219 0.000
F69 Unspecified disorder of adult personality and behaviour
0.780 0.220 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.780 0.220 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.779 0.221 0.000
M05-M14 Inflammatory polyarthropathies
0.605 0.221 0.173
F41.9 Anxiety disorder, unspecified
0.776 0.224 0.000
M06 Other rheumatoid arthritis
0.278 0.224 0.497
Chapter XXII Codes for special purposes
0.775 0.225 0.000
F40 Phobic anxiety disorders
0.772 0.228 0.000
T51.0 Ethanol
0.771 0.229 0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.770 0.230 0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.770 0.230 0.000
F30.9 Manic episode, unspecified
0.765 0.235 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.762 0.238 0.000
G93 Other disorders of brain
0.761 0.239 0.000
G50 Disorders of trigeminal nerve
0.760 0.240 0.000
J37 Chronic laryngitis and laryngotracheitis
0.000 0.240 0.759
M07.3 Other psoriatic arthropathies
0.755 0.241 0.004
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.759 0.241 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.757 0.242 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.751 0.248 0.001
T80-T88 Complications of surgical and medical care, not elsewhere classified
0.749 0.251 0.000
G24 Dystonia
0.748 0.252 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.748 0.252 0.000
J40 Bronchitis, not specified as acute or chronic
0.000 0.254 0.746
G58 Other mononeuropathies
0.746 0.254 0.000
S32 Fracture of lumbar spine and pelvis
0.745 0.255 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
0.742 0.257 0.001
F17.2 Dependence syndrome
0.743 0.257 0.000
M07 Psoriatic and enteropathic arthropathies
0.668 0.257 0.075
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.739 0.261 0.000
G56.1 Other lesions of median nerve
0.738 0.262 0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.737 0.263 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.737 0.263 0.000
S20-S29 Injuries to the thorax
0.732 0.268 0.000
G70.0 Myasthenia gravis
0.732 0.268 0.000
T88 Other complications of surgical and medical care, not elsewhere classified
0.731 0.269 0.000
J46 Status asthmaticus
0.000 0.271 0.729
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.728 0.272 0.000
J84.9 Interstitial pulmonary disease, unspecified
0.000 0.272 0.728
G51.9 Disorder of facial nerve, unspecified
0.728 0.272 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.727 0.273 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.724 0.276 0.000
T39.0 Salicylates
0.723 0.276 0.000
G51.3 Clonic hemifacial spasm
0.721 0.279 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.279 0.721
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.721 0.279 0.000
T42.1 Iminostilbenes
0.720 0.280 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.719 0.281 0.000
H90-H95 Other disorders of ear
0.717 0.283 0.000
L40.4 Guttate psoriasis
0.717 0.283 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
L40.1 Generalised pustular psoriasis
0.717 0.283 0.000
J41 Simple and mucopurulent chronic bronchitis
0.000 0.283 0.717
J45.8 Mixed asthma
0.000 0.283 0.717
J45.1 Nonallergic asthma
0.000 0.283 0.717
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.717 0.283 0.000
F70-F79 Mental retardation
0.717 0.283 0.000
J33.1 Polypoid sinus degeneration
0.000 0.283 0.717
F38 Other mood [affective] disorders
0.716 0.284 0.000
F39 Unspecified mood [affective] disorder
0.716 0.284 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.716 0.284 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.715 0.285 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.715 0.285 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.715 0.285 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.715 0.285 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.715 0.285 0.000
T36 Poisoning by systemic antibiotics
0.715 0.285 0.000
L44 Other papulosquamous disorders
0.715 0.285 0.000
L41 Parapsoriasis
0.715 0.285 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.715 0.285 0.000
T33-T35 Frostbite
0.714 0.286 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.714 0.286 0.000
T00-T07 Injuries involving multiple body regions
0.714 0.286 0.000
L10-L14 Bullous disorders
0.713 0.287 0.000
F48 Other neurotic disorders
0.710 0.290 0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.000 0.290 0.710
S39 Other and unspecified injuries of abdomen, lower back and pelvis
0.710 0.290 0.000
F32.9 Depressive episode, unspecified
0.710 0.290 0.000
J32.9 Chronic sinusitis, unspecified
0.000 0.292 0.708
J01 Acute sinusitis
0.000 0.292 0.708
T47.1 Other antacids and anti-gastric-secretion drugs
0.707 0.293 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.707 0.293 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.707 0.293 0.000
T39.4 Antirheumatics, not elsewhere classified
0.707 0.293 0.000
T39.2 Pyrazolone derivatives
0.707 0.293 0.000
F31.7 Bipolar affective disorder, currently in remission
0.706 0.294 0.000
F31.6 Bipolar affective disorder, current episode mixed
0.706 0.294 0.000
G61 Inflammatory polyneuropathy
0.705 0.295 0.000
F32.1 Moderate depressive episode
0.705 0.295 0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.705 0.295 0.000
G52 Disorders of other cranial nerves
0.703 0.296 0.000
F80-F89 Disorders of psychological development
0.702 0.298 0.000
G96 Other disorders of central nervous system
0.702 0.298 0.000
F68 Other disorders of adult personality and behaviour
0.700 0.300 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.700 0.300 0.000
F65 Disorders of sexual preference
0.700 0.300 0.000
F64 Gender identity disorders
0.700 0.300 0.000
F63 Habit and impulse disorders
0.700 0.300 0.000
F62 Enduring personality changes, not attributable to brain damage and disease
0.700 0.300 0.000
F61 Mixed and other personality disorders
0.700 0.300 0.000
G56.9 Mononeuropathy of upper limb, unspecified
0.699 0.301 0.000
G56.4 Causalgia
0.699 0.301 0.000
G56.3 Lesion of radial nerve
0.699 0.301 0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.301 0.699
T50.9 Other and unspecified drugs, medicaments and biological substances
0.695 0.305 0.000
G60 Hereditary and idiopathic neuropathy
0.694 0.306 0.000
J32.4 Chronic pansinusitis
0.000 0.306 0.694
F45.8 Other somatoform disorders
0.693 0.307 0.000
T79-T79 Certain early complications of trauma
0.693 0.307 0.000
F41.8 Other specified anxiety disorders
0.691 0.309 0.000
F41.3 Other mixed anxiety disorders
0.691 0.309 0.000
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.309 0.691
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.309 0.691
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.309 0.691
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.309 0.691
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.691 0.309 0.000
Q00-Q07 Congenital malformations of the nervous system
0.691 0.309 0.000
S31 Open wound of abdomen, lower back and pelvis
0.691 0.309 0.000
G90 Disorders of autonomic nervous system
0.691 0.309 0.000
J81 Pulmonary oedema
0.000 0.311 0.689
J36 Peritonsillar abscess
0.000 0.312 0.688
T88.7 Unspecified adverse effect of drug or medicament
0.686 0.314 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.685 0.314 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.685 0.314 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.685 0.314 0.000
T42.3 Barbiturates
0.685 0.314 0.000
T42.2 Succinimides and oxazolidinediones
0.685 0.314 0.000
T42.0 Hydantoin derivatives
0.685 0.314 0.000
G93.1 Anoxic brain damage, not elsewhere classified
0.684 0.316 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.684 0.316 0.000
Q35-Q37 Cleft lip and cleft palate
0.684 0.316 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.684 0.316 0.000
F60.8 Other specific personality disorders
0.683 0.317 0.000
F60.7 Dependent personality disorder
0.683 0.317 0.000
F60.6 Anxious [avoidant] personality disorder
0.683 0.317 0.000
F60.5 Anankastic personality disorder
0.683 0.317 0.000
F60.4 Histrionic personality disorder
0.683 0.317 0.000
F60.2 Dissocial personality disorder
0.683 0.317 0.000
F60.1 Schizoid personality disorder
0.683 0.317 0.000
F60.0 Paranoid personality disorder
0.683 0.317 0.000
Q82 Other congenital malformations of skin
0.678 0.322 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.677 0.323 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.325 0.675
Chapter XIII Diseases of the musculoskeletal system and connective tissue
0.604 0.325 0.071
L52 Erythema nodosum
0.674 0.326 0.000
F44.5 Dissociative convulsions
0.673 0.327 0.000
Q51 Congenital malformations of uterus and cervix
0.673 0.327 0.000
S90-S99 Injuries to the ankle and foot
0.670 0.330 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.669 0.331 0.000
F44.9 Dissociative [conversion] disorder, unspecified
0.669 0.331 0.000
S70-S79 Injuries to the hip and thigh
0.668 0.332 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.668 0.332 0.000
F30.8 Other manic episodes
0.667 0.333 0.000
F30.2 Mania with psychotic symptoms
0.667 0.333 0.000
F30.1 Mania without psychotic symptoms
0.667 0.333 0.000
F33.9 Recurrent depressive disorder, unspecified
0.665 0.335 0.000
Q21 Congenital malformations of cardiac septa
0.662 0.338 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.661 0.339 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.659 0.341 0.000
G91 Hydrocephalus
0.658 0.342 0.000
G30-G32 Other degenerative diseases of the nervous system
0.657 0.343 0.000
J39 Other diseases of upper respiratory tract
0.000 0.343 0.657
S40-S49 Injuries to the shoulder and upper arm
0.655 0.345 0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.000 0.346 0.654
G51.8 Other disorders of facial nerve
0.654 0.346 0.000
G51.4 Facial myokymia
0.654 0.346 0.000
G51.2 Melkersson's syndrome
0.654 0.346 0.000
G51.1 Geniculate ganglionitis
0.654 0.346 0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.000 0.347 0.653
Q83 Congenital malformations of breast
0.652 0.348 0.000
F99-F99 Unspecified mental disorder
0.651 0.349 0.000
G24.9 Dystonia, unspecified
0.650 0.350 0.000
J32.3 Chronic sphenoidal sinusitis
0.000 0.350 0.650
J32.1 Chronic frontal sinusitis
0.000 0.350 0.650
F32.2 Severe depressive episode without psychotic symptoms
0.649 0.351 0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.649 0.351 0.000
G53 Cranial nerve disorders in diseases classified elsewhere
0.647 0.353 0.000
G56.8 Other mononeuropathies of upper limb
0.644 0.355 0.000
J84.1 Other interstitial pulmonary diseases with fibrosis
0.000 0.355 0.645
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.644 0.356 0.000
T65 Toxic effect of other and unspecified substances
0.644 0.356 0.000
T63 Toxic effect of contact with venomous animals
0.644 0.356 0.000
T62 Toxic effect of other noxious substances eaten as food
0.644 0.356 0.000
T61 Toxic effect of noxious substances eaten as seafood
0.644 0.356 0.000
T60 Toxic effect of pesticides
0.644 0.356 0.000
T59 Toxic effect of other gases, fumes and vapours
0.644 0.356 0.000
T57 Toxic effect of other inorganic substances
0.644 0.356 0.000
T56 Toxic effect of metals
0.644 0.356 0.000
T54 Toxic effect of corrosive substances
0.644 0.356 0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone
0.644 0.356 0.000
T52 Toxic effect of organic solvents
0.644 0.356 0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants
0.644 0.356 0.000
T58 Toxic effect of carbon monoxide
0.644 0.356 0.000
T55 Toxic effect of soaps and detergents
0.644 0.356 0.000
J30.1 Allergic rhinitis due to pollen
0.000 0.356 0.643
S32.4 Fracture of acetabulum
0.643 0.357 0.000
G54 Nerve root and plexus disorders
0.642 0.358 0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.641 0.359 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.641 0.359 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.641 0.359 0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.641 0.359 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.641 0.359 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.641 0.359 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.640 0.360 0.000
H93 Other disorders of ear, not elsewhere classified
0.639 0.361 0.000
H91 Other hearing loss
0.639 0.361 0.000
F33.8 Other recurrent depressive disorders
0.638 0.362 0.000
F33.4 Recurrent depressive disorder, currently in remission
0.638 0.362 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.638 0.362 0.000
Q60-Q64 Congenital malformations of the urinary system
0.637 0.363 0.000
E10.9 Without complications
0.000 0.364 0.636
Q54 Hypospadias
0.636 0.364 0.000
G59 Mononeuropathy in diseases classified elsewhere
0.634 0.365 0.000
G23 Other degenerative diseases of basal ganglia
0.634 0.366 0.000
G21 Secondary Parkinsonism
0.634 0.366 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.634 0.366 0.000
G22 Parkinsonism in diseases classified elsewhere
0.634 0.366 0.000
Q76 Congenital malformations of spine and bony thorax
0.634 0.366 0.000
F32.0 Mild depressive episode
0.634 0.366 0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis
0.000 0.367 0.633
T38.9 Other and unspecified hormone antagonists
0.632 0.368 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.632 0.368 0.000
T38.7 Androgens and anabolic congeners
0.632 0.368 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.632 0.368 0.000
T38.5 Other oestrogens and progestogens
0.632 0.368 0.000
T38.4 Oral contraceptives
0.632 0.368 0.000
T38.2 Antithyroid drugs
0.632 0.368 0.000
T38.1 Thyroid hormones and substitutes
0.632 0.368 0.000
T38.0 Glucocorticoids and synthetic analogues
0.632 0.368 0.000
J82 Pulmonary eosinophilia, not elsewhere classified
0.000 0.368 0.632
F42.9 Obsessive-compulsive disorder, unspecified
0.632 0.368 0.000
F11 Mental and behavioural disorders due to use of opioids
0.631 0.369 0.000
Q89 Other congenital malformations, not elsewhere classified
0.630 0.370 0.000
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis
0.629 0.371 0.000
S37 Injury of urinary and pelvic organs
0.629 0.371 0.000
S36 Injury of intra-abdominal organs
0.629 0.371 0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level
0.629 0.371 0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level
0.629 0.371 0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis
0.629 0.371 0.000
G82 Paraplegia and tetraplegia
0.629 0.371 0.000
F34.1 Dysthymia
0.625 0.375 0.000
E10 Insulin-dependent diabetes mellitus
0.002 0.375 0.623
G63 Polyneuropathy in diseases classified elsewhere
0.625 0.375 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.624 0.376 0.000
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere
0.624 0.376 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.623 0.377 0.000
J32.2 Chronic ethmoidal sinusitis
0.000 0.377 0.623
J30.3 Other allergic rhinitis
0.000 0.378 0.622
M07.34 Other psoriatic arthropathies (Hand)
0.619 0.379 0.002
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand
0.620 0.379 0.000
J04 Acute laryngitis and tracheitis
0.000 0.380 0.620
F17.9 Unspecified mental and behavioural disorder
0.620 0.380 0.000
F17.8 Other mental and behavioural disorders
0.620 0.380 0.000
F17.7 Residual and late-onset psychotic disorder
0.620 0.380 0.000
F17.6 Amnesic syndrome
0.620 0.380 0.000
F17.5 Psychotic disorder
0.620 0.380 0.000
F17.4 Withdrawal state with delirium
0.620 0.380 0.000
F17.3 Withdrawal state
0.620 0.380 0.000
F17.0 Acute intoxication
0.620 0.380 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.617 0.380 0.002
T88.4 Failed or difficult intubation
0.620 0.380 0.000
T51.9 Alcohol, unspecified
0.620 0.380 0.000
Q18 Other congenital malformations of face and neck
0.619 0.381 0.000
F32.8 Other depressive episodes
0.619 0.381 0.000
S19 Other and unspecified injuries of neck
0.619 0.381 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.619 0.381 0.000
G98 Other disorders of nervous system, not elsewhere classified
0.619 0.381 0.000
G92 Toxic encephalopathy
0.619 0.381 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.619 0.381 0.000
G71 Primary disorders of muscles
0.618 0.381 0.000
L50 Urticaria
0.617 0.383 0.000
S10 Superficial injury of neck
0.616 0.384 0.000
T43.9 Psychotropic drug, unspecified
0.616 0.384 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.616 0.384 0.000
T43.6 Psychostimulants with abuse potential
0.616 0.384 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.616 0.384 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.616 0.384 0.000
J03.8 Acute tonsillitis due to other specified organisms
0.000 0.385 0.615
J03.0 Streptococcal tonsillitis
0.000 0.385 0.615
G64 Other disorders of peripheral nervous system
0.614 0.386 0.000
F43 Reaction to severe stress, and adjustment disorders
0.612 0.388 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.610 0.390 0.000
G72 Other myopathies
0.610 0.390 0.000
G62 Other polyneuropathies
0.609 0.391 0.000
F40.0 Agoraphobia
0.608 0.392 0.000
T23 Burn and corrosion of wrist and hand
0.604 0.396 0.000
E10.3 With ophthalmic complications
0.000 0.397 0.603
G50.0 Trigeminal neuralgia
0.602 0.398 0.000
J69 Pneumonitis due to solids and liquids
0.000 0.400 0.600
T91 Sequelae of injuries of neck and trunk
0.599 0.401 0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.598 0.402 0.000
F44.8 Other dissociative [conversion] disorders
0.598 0.402 0.000
F44.7 Mixed dissociative [conversion] disorders
0.598 0.402 0.000
F44.6 Dissociative anaesthesia and sensory loss
0.598 0.402 0.000
F44.4 Dissociative motor disorders
0.598 0.402 0.000
F44.3 Trance and possession disorders
0.598 0.402 0.000
F44.2 Dissociative stupor
0.598 0.402 0.000
F44.1 Dissociative fugue
0.598 0.402 0.000
F44.0 Dissociative amnesia
0.598 0.402 0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
0.595 0.405 0.000
Q84 Other congenital malformations of integument
0.595 0.405 0.000
Q81 Epidermolysis bullosa
0.595 0.405 0.000
Q80 Congenital ichthyosis
0.595 0.405 0.000
L43 Lichen planus
0.594 0.405 0.000
T88.8 Other specified complications of surgical and medical care, not elsewhere classified
0.594 0.406 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.594 0.406 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.594 0.406 0.000
T47.7 Emetics
0.594 0.406 0.000
T47.6 Antidiarrhoeal drugs
0.594 0.406 0.000
T47.5 Digestants
0.594 0.406 0.000
T47.4 Other laxatives
0.594 0.406 0.000
T47.3 Saline and osmotic laxatives
0.594 0.406 0.000
T47.2 Stimulant laxatives
0.594 0.406 0.000
T47.0 Histamine H(2)-receptor antagonists
0.594 0.406 0.000
T51.8 Other alcohols
0.593 0.407 0.000
T51.3 Fusel oil
0.593 0.407 0.000
T51.2 2-Propanol
0.593 0.407 0.000
T51.1 Methanol
0.593 0.407 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.590 0.407 0.003
L53 Other erythematous conditions
0.591 0.409 0.000
T20 Burn and corrosion of head and neck
0.590 0.409 0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis
0.589 0.411 0.000
T50.8 Diagnostic agents
0.589 0.411 0.000
T50.7 Analeptics and opioid receptor antagonists
0.589 0.411 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.589 0.411 0.000
T50.5 Appetite depressants
0.589 0.411 0.000
T50.4 Drugs affecting uric acid metabolism
0.589 0.411 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.589 0.411 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.589 0.411 0.000
T50.1 Loop [high-ceiling] diuretics
0.589 0.411 0.000
T50.0 Mineralocorticoids and their antagonists
0.589 0.411 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.588 0.411 0.000
G93.3 Postviral fatigue syndrome
0.588 0.412 0.000
L54 Erythema in diseases classified elsewhere
0.588 0.412 0.000
L51 Erythema multiforme
0.588 0.412 0.000
J37.0 Chronic laryngitis
0.000 0.412 0.588
F45.9 Somatoform disorder, unspecified
0.586 0.414 0.000
F45.4 Persistent somatoform pain disorder
0.586 0.414 0.000
F45.3 Somatoform autonomic dysfunction
0.586 0.414 0.000
F45.2 Hypochondriacal disorder
0.586 0.414 0.000
F45.1 Undifferentiated somatoform disorder
0.586 0.414 0.000
F45.0 Somatisation disorder
0.586 0.414 0.000
G61.8 Other inflammatory polyneuropathies
0.585 0.415 0.000
J01.9 Acute sinusitis, unspecified
0.000 0.417 0.583
Chapter IX Diseases of the circulatory system
0.583 0.417 0.000
H91.9 Hearing loss, unspecified
0.583 0.417 0.000
Q51.3 Bicornate uterus
0.583 0.417 0.000
T80 Complications following infusion, transfusion and therapeutic injection
0.581 0.419 0.000
S32.1 Fracture of sacrum
0.579 0.421 0.000
J70 Respiratory conditions due to other external agents
0.000 0.422 0.578
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.000 0.422 0.578
J67 Hypersensitivity pneumonitis due to organic dust
0.000 0.422 0.578
J66 Airway disease due to specific organic dust
0.000 0.422 0.578
J63 Pneumoconiosis due to other inorganic dusts
0.000 0.422 0.578
J62 Pneumoconiosis due to dust containing silica
0.000 0.422 0.578
J65 Pneumoconiosis associated with tuberculosis
0.000 0.422 0.578
J64 Unspecified pneumoconiosis
0.000 0.422 0.578
J60 Coalworker's pneumoconiosis
0.000 0.422 0.578
G60.0 Hereditary motor and sensory neuropathy
0.578 0.422 0.000
G93.9 Disorder of brain, unspecified
0.577 0.423 0.000
J84.8 Other specified interstitial pulmonary diseases
0.000 0.423 0.577
J84.0 Alveolar and parietoalveolar conditions
0.000 0.423 0.577
T18 Foreign body in alimentary tract
0.577 0.423 0.000
S32.0 Fracture of lumbar vertebra
0.576 0.424 0.000
F32.3 Severe depressive episode with psychotic symptoms
0.576 0.424 0.000
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified
0.573 0.426 0.000
Q56 Indeterminate sex and pseudohermaphroditism
0.573 0.426 0.000
Q55 Other congenital malformations of male genital organs
0.573 0.426 0.000
Q53 Undescended testicle
0.573 0.426 0.000
Q52 Other congenital malformations of female genitalia
0.573 0.426 0.000
T25 Burn and corrosion of ankle and foot
0.573 0.427 0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot
0.573 0.427 0.000
T21 Burn and corrosion of trunk
0.573 0.427 0.000
H65-H75 Diseases of middle ear and mastoid
0.572 0.428 0.000
S32.40 Fracture of acetabulum (closed)
0.570 0.430 0.000
T83 Complications of genito-urinary prosthetic devices, implants and grafts
0.570 0.430 0.000
S79 Other and unspecified injuries of hip and thigh
0.568 0.432 0.000
G90.3 Multisystem degeneration
0.567 0.433 0.000
S17 Crushing injury of neck
0.567 0.433 0.000
S15 Injury of blood vessels at neck level
0.567 0.433 0.000
S14 Injury of nerves and spinal cord at neck level
0.567 0.433 0.000
S13 Dislocation, sprain and strain of joints and ligaments at neck level
0.567 0.433 0.000
S11 Open wound of neck
0.567 0.433 0.000
S18 Traumatic amputation at neck level
0.567 0.433 0.000
S16 Injury of muscle and tendon at neck level
0.567 0.433 0.000
G70.9 Myoneural disorder, unspecified
0.566 0.434 0.000
G70.8 Other specified myoneural disorders
0.566 0.434 0.000
G70.2 Congenital and developmental myasthenia
0.566 0.434 0.000
G70.1 Toxic myoneural disorders
0.566 0.434 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.566 0.434 0.000
S22 Fracture of rib(s), sternum and thoracic spine
0.565 0.435 0.000
J30.2 Other seasonal allergic rhinitis
0.000 0.436 0.564
J30.0 Vasomotor rhinitis
0.000 0.436 0.564
S30 Superficial injury of abdomen, lower back and pelvis
0.563 0.436 0.000
F40.2 Specific (isolated) phobias
0.563 0.437 0.000
J32.8 Other chronic sinusitis
0.000 0.437 0.563

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.